Financial reimbursement for clinical trial participation costs: a pilot feasibility study
JNCI Cancer Spectrum · 09.05.2026 · 10 (3)
DOI: 10.1093/jncics/pkag048 ↗Kurz gefasst
Klinische Studie in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 03.05.2026. Verfasst von Courtney P Williams und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine & Population Science, University of Alabama at Birmingham, Birmingham, AL, United States. Hauptthemen laut MEDLINE: Breast Neoplasms, Clinical Trials as Topic, Patient Selection. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Breast Cancer Research Foundation of Alabama, UAB O'Neal Comprehensive Cancer Center O'Neal Invests, Community Foundation of Greater Birmingham Women's Breast Health Fund.
Abstract (Originalsprache)
Background
Clinical trial participants rarely represent the real-world treatment population, potentially due to costs associated with participation. Monetary reimbursement for trial-related costs could address financial barriers to trial recruitment and retention.
Methods
This mixed-methods, pilot, feasibility study provided financial reimbursement to women with breast cancer participating in a clinical trial. Patients were reimbursed $1000/month during their first 4 months of trial participation, surveyed biweekly to assess changes in financial toxicity, and then interviewed to explore the effects of receiving reimbursement on trial-related costs and recruitment and retention. Mixed-effect modeling and thematic analysis were completed. Feasibility was defined as 80% retention of patients on the reimbursement study, with those retained completing 75% of surveys.
Results
Of 39 consented patients, 33 patients completed the pilot study (85% retention, 100% survey completion). Patients were a median 52 years old (interquartile range = 44-59), 48% Black, 67% privately insured, and 42% found it difficult to live on their current income. Patient financial toxicity modestly decreased. Patients (n = 32) reported using the reimbursement to pay for trial visit-related food, transportation, caregiver expenses, and out-of-pocket medical costs. Patients felt receiving reimbursement affected trial retention more so than recruitment, stating “I would have enrolled regardless … [but knowing] it wasn’t going to place a financial strain on us because of these reimbursements. … It made it easier for me to feel good about continuing.” Conclusion Reimbursement for clinical trial-related costs is feasible, suggests decreases in financial toxicity, and is a promising approach to improve trial retention outcomes in women with breast cancer. ClinicalTrials.gov ID NCT05871125
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of General Internal Medicine & Population Science, University of Alabama at Birmingham, Birmingham, AL, United States.
- O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States.
- Division of Hematology & Oncology, University of Alabama at Birmingham, Birmingham, AL, United States.
- School of Nursing, University of Alabama at Birmingham, Birmingham, AL, United States.
- Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States.
ORCID-Profile: Courtney P Williams, Nicole L Henderson, Nusrat Jahan, Andres Azuero, Maria Pisu, Gabrielle B Rocque
Förderung
- Breast Cancer Research Foundation of Alabama
- UAB O'Neal Comprehensive Cancer Center O'Neal Invests
- Community Foundation of Greater Birmingham Women's Breast Health Fund
- UAB O’Neal Comprehensive Cancer Center O’Neal Invests
- Community Foundation of Greater Birmingham Women’s Breast Health Fund
Zitieren
APA
Williams, C. P., Henderson, N. L., Jahan, N., Stringer-Reasor, E., Azuero, A., Pisu, M., Arend, R. C., & Rocque, G. B. (2026). Financial reimbursement for clinical trial participation costs: a pilot feasibility study. JNCI Cancer Spectrum, 10(3). https://doi.org/10.1093/jncics/pkag048
Vancouver
Williams CP, Henderson NL, Jahan N, Stringer-Reasor E, Azuero A, Pisu M, et al. Financial reimbursement for clinical trial participation costs: a pilot feasibility study. JNCI Cancer Spectrum. 2026;10(3). doi:10.1093/jncics/pkag048
BibTeX
@article{Williams2026,
author = {Williams, Courtney P and Henderson, Nicole L and Jahan, Nusrat and Stringer-Reasor, Erica and Azuero, Andres and Pisu, Maria and Arend, Rebecca C and Rocque, Gabrielle B},
title = {Financial reimbursement for clinical trial participation costs: a pilot feasibility study},
journal = {JNCI Cancer Spectrum},
year = {2026},
volume = {10},
number = {3},
doi = {10.1093/jncics/pkag048}
}
EUVIMED